Informing the drug development and commercialization industry Cary, N.C. – June 20, 2013 – Industry Standard Research (ISR) today announced the release of a new market research report titled “EMRs and Clinical Research: Current and Potential Impact.” This report provides the pharmaceutical industry and its service providers with novel insights into the current and future use of electronic medical records (EMRs) by clinical sites for clinical development. “While government incentive programs have driven the adoption of EMRs, ISR has found that investigative sites are still in the early stages of optimizing these technologies to positively impact clinical research,” Andrew Schafer, President of ISR explained. “ISR’s newest report found that just because a medical practice has an EMR system installed, does not mean that they have integrated the system into the clinical research workflow.” ISR’s study highlights significant opportunity for EMR vendors and trial sponsors. ISR surveyed 102 site coordinators and principal investigators with responsibility for clinical research and the analysis allows readers to:
  • Learn how sites currently use EMRs for various clinical trial activities
  • Understand the impact EMRs are having on patient recruitment and feasibility assessments
  • Identify which EMR vendors are being used and which have the highest satisfaction ratings
  • Uncover methods to better manage relationships with investigative sites
  • Receive recommendations to improve trial efficiency
  • Compare end-user satisfaction ratings across several major EMR platforms
For more information about ISR’s report, please visit its website at https://isrreports.com/product/emrs-and-clinical-research-current-and-potential-impact/ About Industry Standard Research Industry Standard Research is the premier, full service market research provider to the pharma and pharma services industries.  With over a decade of experience, ISR delivers an unmatched level of domain expertise.  For more information about our off-the-shelf intelligence and custom research offerings, please visit the company’s Web site at www.ISRreports.com, email info@ISRreports.com, or follow us on Twitter @ISRreports.

ISR CUSTOMERS